Fate Therapeutics Inc. sell StockNews.com
Start price
10.08.25
/
50%
€0.78
Target price
10.08.26
-
Performance (%)
10.76%
Price
16:35
€0.88
Summary
This prediction is currently active. The prediction currently has a disappointing performance of 10.76%. This prediction currently runs until 10.08.26. The prediction end date can be changed by StockNews_com at any time. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Fate Therapeutics Inc. | -6.204% | -6.204% |
| iShares Core DAX® | 1.330% | -1.723% |
| iShares Nasdaq 100 | 1.099% | -2.569% |
| iShares Nikkei 225® | 1.265% | -6.613% |
| iShares S&P 500 | 1.000% | -0.871% |
Comments by StockNews_com for this prediction
In the thread Fate Therapeutics Inc. diskutieren
Fate Therapeutics, Inc. (NASDAQ: FATE) was downgraded by analysts at Wall Street Zen from a "hold" rating to a "sell" rating.
Ratings data for FATE provided by MarketBeat
Stopped prediction by StockNews_com for Fate Therapeutics Inc.
Fate Therapeutics Inc.
Start price
Target price
Perf. (%)
€4.15
11.05.24
11.05.24
-
11.05.25
11.05.25
-76.44%
12.05.25
12.05.25
